APA

Sarsour K., Greenberg J., Johnston J. A., Nelson D. R., O'Brien L. A., Oddoux C., Ostrer H., Pearlman A. & Reed G. (20130626). The role of the FcGRIIIa polymorphism in modifying the association between treatment and outcome in patients with rheumatoid arthritis treated with rituximab versus TNF-α antagonist therapies. : Clinical and experimental rheumatology.

Chicago

Sarsour Khaled, Greenberg Jeffrey, Johnston Joseph A, Nelson David R, O'Brien Lee A, Oddoux Carole, Ostrer Harry, Pearlman Alex and Reed George. 20130626. The role of the FcGRIIIa polymorphism in modifying the association between treatment and outcome in patients with rheumatoid arthritis treated with rituximab versus TNF-α antagonist therapies. : Clinical and experimental rheumatology.

Harvard

Sarsour K., Greenberg J., Johnston J. A., Nelson D. R., O'Brien L. A., Oddoux C., Ostrer H., Pearlman A. and Reed G. (20130626). The role of the FcGRIIIa polymorphism in modifying the association between treatment and outcome in patients with rheumatoid arthritis treated with rituximab versus TNF-α antagonist therapies. : Clinical and experimental rheumatology.

MLA

Sarsour Khaled, Greenberg Jeffrey, Johnston Joseph A, Nelson David R, O'Brien Lee A, Oddoux Carole, Ostrer Harry, Pearlman Alex and Reed George. The role of the FcGRIIIa polymorphism in modifying the association between treatment and outcome in patients with rheumatoid arthritis treated with rituximab versus TNF-α antagonist therapies. : Clinical and experimental rheumatology. 20130626.